09 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-fda-advisory-committee-meeting-to-review-elamipretide-for-barth-syndrome-treatment-302242393.html
29 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stealth-biotherapeutics-completes-mid-cycle-review-meeting-on-elamipretide-for-the-treatment-of-barth-syndrome-302207846.html
05 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-first-patient-enrolled-in-global-phase-3-clinical-program-for-elamipretide-in-patients-with-dry-age-related-macular-degeneration-302164947.html
07 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stealth-biotherapeutics-barth-syndrome-nda-receives-priority-review-designation-302138192.html
09 Apr 2024
// Zachary Brennan ENDPTS
https://endpts.com/stealth-bio-gets-fda-adcomm-for-previously-rejected-ultra-rare-disease-drug/
08 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/stealth-biotherapeutics-announces-fda-acceptance-of-new-drug-application-for-elamipretide-for-the-treatment-of-barth-syndrome-302109608.html
LOOKING FOR A SUPPLIER?